Top Markets
#1 EXOD EXOD +22.08%
#2 The Black Bull The Black Bull +20.99%
#3 Useless Coin Useless Coin +20.35%
#4 SSV Network SSV Network +20.00%
#5 XPIN Network XPIN Network +19.35%
#6 Ore Ore +18.69%
#7 Binance-Peg Bitcoin Cash Binance-Peg Bitcoin Cash +18.29%
#8 Derive Derive +17.93%
#9 Berachain Berachain +17.70%
#10 Bitcoin Cash Bitcoin Cash +17.45%
Coin of the day
EXOD EXOD
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
Orexo AB Orexo AB

Orexo AB

ORX
Kedudukan dalam Saham #24964
Orexo AB (publ), a specialty pharmaceutical company, develops and... Orexo AB (publ), a specialty pharmaceutical company, develops and commercializes pharmaceuticals and digital therapies in the United States, European Union, the United Kingdom, and internationally. Its products include Zubsolv tablets for the treatment of opioid use disorder; Abstral for the treatment of breakthrough pain in cancer patients; and Edluar for the treatment of insomnia. The company is developing OX124 for opioid overdose; OX125 for rescue medication and opioid overdose; OX640 to treat anaphylaxis with powder-based epinephrine; and OX-MPI for the treatment of endometriosis. Its digital therapies include deprexis for the treatment of depression; vorvida for alcohol management; and modia for opioid use disorder. The company has a collaboration agreement with Abera Bioscience AB to develop nasal powder vaccines based on the AmorphOX technology. Orexo AB (publ) was founded in 1994 and is headquartered in Uppsala, Sweden.
Harga Saham
$1.56
Modal Pasaran
$54.77M
Perubahan (1 hari)
-0.43%
Perubahan (1 tahun)
-29.25%
Negara
SE
Perdagangan Orexo AB (ORX)

Kategori

Healthcare
Hasil untuk Orexo AB (ORX)
Hasil pada Aug 2026 TTM: 0
Menurut laporan kewangan terkini daripada Orexo AB, hasil semasa syarikat (TTM) ialah 0. Pada tahun 2026, syarikat memperoleh hasil sebanyak 0 sama dengan hasil pada tahun 2026 iaitu 0. Hasil ialah jumlah pendapatan keseluruhan yang dijana oleh syarikat daripada jualan barangan atau perkhidmatan. Tidak seperti keuntungan, tiada perbelanjaan ditolak.
Sejarah hasil bagi Orexo AB dari 2026 hingga 2026
Hasil pada akhir setiap tahun
Tahun Hasil Ubah
Tidak cukup data untuk tarikh yang disediakan.
Hasil untuk syarikat atau pesaing serupa
Syarikat Hasil Perbezaan Hasil Negara
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
 $2.54B -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
 - -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
 - -
FR
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
 $830.81M -
US
Sino Biopharmaceutical Limited Sino Biopharmaceutical Limited
Sino Biopharmaceutical Limited
1177.HK
 $4.55B -
HK